# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-024353
Filing Date
2024-03-04
Accepted
2024-03-04 08:00:24
Documents
16
Period of Report
2024-04-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | amrn-20240304.htm iXBRL | DEF 14A | 2656287
2 | GRAPHIC | img153232652_0.jpg | GRAPHIC | 7700
3 | GRAPHIC | img153232652_1.jpg | GRAPHIC | 39171
4 | GRAPHIC | img153232652_2.jpg | GRAPHIC | 34080
5 | GRAPHIC | img153232652_3.jpg | GRAPHIC | 33870
| Complete submission text file | 0000950170-24-024353.txt |  | 4178958

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | amrn-20240304.xsd | EX-101.SCH | 39912
17 | EXTRACTED XBRL INSTANCE DOCUMENT | amrn-20240304_htm.xml | XML | 384330

Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21392 | Film No.: 24712878
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)